Immutep
IMMP
$2.64
Share price
2.12%
Change (1 day)
62.27%
Change (1 year)
Categories
Immutep (IMMP) - P/B ratio
P/B ratio as of April 2024 : 3.41
According to Immutep's latest financial reports the company has a price-to-book ratio of 3.41.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Immutep - P/B ratio (from 2012 to 2023)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2023-12-31 | 3.16 | 1.33% |
| 2022-12-31 | 3.12 | -7.42% |
| 2021-12-31 | 3.37 | -24.01% |
| 2020-12-31 | 4.43 | 22.86% |
| 2019-12-31 | 3.61 | 29.12% |
| 2018-12-31 | 2.79 | 45.9% |
| 2017-12-31 | 1.91 | -20.05% |
| 2016-12-31 | 2.39 | -7.54% |
| 2015-12-31 | 2.59 | 31.17% |
| 2014-12-31 | 1.97 | 23.62% |
| 2013-12-31 | 1.60 | -60.01% |
| 2012-12-31 | 3.99 |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 Illumina ILMN | 3.41 | -0.07% | 🇺🇸 USA |
 FibroGen FGEN | -0.5994 | -117.59% | 🇺🇸 USA |
 HTG Molecular Diagnostics
HTGM | 0.1971 | -94.22% | 🇺🇸 USA |